D07.30 - Carcinoma in situ of unspecified female genital organs
| ICD-10: | D07.30 |
| Short Description: | Carcinoma in situ of unspecified female genital organs |
| Long Description: | Carcinoma in situ of unspecified female genital organs |
| Status: | Valid for Submission |
| Version: | ICD-10-CM 2023 |
| Code Classification: |
D07.30 is a billable ICD-10 code used to specify a medical diagnosis of carcinoma in situ of unspecified female genital organs. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
This code is applicable to female patients only. It is clinically and virtually impossible to use this code on a non-female patient.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic genital organ or tract ; Neoplasm, neoplastic genital organ or tract female NEC ; Neoplasm, neoplastic genitourinary tract ; Neoplasm, neoplastic genitourinary tract female ; Neoplasm, neoplastic septum urethrovaginal ; Neoplasm, neoplastic septum vesicovaginal ; Neoplasm, neoplastic urethrovaginal (septum) ; etc
Unspecified diagnosis codes like D07.30 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Carcinoma in situ of female genital organ
- Intraepithelial squamous cell carcinoma of anogenital region
Code Edits
The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10 Code Edits are applicable to this code:
- Diagnoses for females only - The Medicare Code Editor detects inconsistencies between a patient’s sex and any diagnosis on the patient’s record, these edits apply to FEMALES only .
Convert to ICD-9 Code
| Source ICD-10 Code | Target ICD-9 Code | |
|---|---|---|
| D07.30 | 233.30 - Ca in situ fem gen NOS |
Table of Neoplasms
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
| Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
|---|---|---|---|---|---|---|
| »Neoplasm, neoplastic »genital organ or tract | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »genital organ or tract »female NEC | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »genitourinary tract | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »genitourinary tract »female | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »septum »urethrovaginal | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »septum »vesicovaginal | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »urethrovaginal (septum) | C57.9 | C79.82 | D07.30 | D28.9 | D39.8 | D49.59 |
| »Neoplasm, neoplastic »vaginovesical | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »vaginovesical »septum | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »vesicocervical tissue | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »vesicovaginal | C57.9 | C79.82 | D07.30 | D28.9 | D39.9 | D49.59 |
| »Neoplasm, neoplastic »vesicovaginal »septum | C57.9 | C79.82 | D07.30 | D28.9 | D39.8 | D49.59 |
Patient Education
Cancer
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Most treatment plans may include surgery, radiation and/or chemotherapy. Some may involve hormone therapy, immunotherapy or other types of biologic therapy, or stem cell transplantation.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)